É. Erdmann

发表

Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation—A new paradigm for cooperation among prostate tumor cells

D. Jacqmin, H. Lang, J. Céraline, 2007, International journal of cancer.

Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer

J. Céraline, T. Ye, L. Negroni, 2021, Molecular oncology.

A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer.

D. Jacqmin, J. Céraline, B. Duclos, 2003, European journal of endocrinology.

Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen‐independent growth in prostate cancer

D. Chopin, D. Jacqmin, J. Céraline, 2004, International journal of cancer.

Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells

J. Céraline, J. Bergerat, J. Kurtz, 2013, PloS one.

Constitutively Active Androgen Receptor Variant Detected in a Human Prostate Cancer

D. Chopin, D. Jacqmin, J. Céraline, 2005 .

Fluorine NMR study of proline-rich sequences using fluoroprolines

Davy Sinnaeve, I. Kuprov, B. Kieffer, 2021, Magnetic Resonance.

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer

J. Céraline, T. Ye, C. Keime, 2017, Oncotarget.

Identification of novel truncated androgen receptor (AR) mutants including unreported pre‐mRNA splicing variants in the 22Rv1 hormone‐refractory prostate cancer (PCa) cell line

J. Céraline, B. Duclos, J. Bergerat, 2010, Human mutation.

Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors

M. Poupon, A. Morin, J. Céraline, 2012, PloS one.

A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions.

J. Céraline, J. Bergerat, P. Kessler, 2007, Endocrinology.

ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder.

H. Mefford, G. Cooper, N. Paul, 2019, American journal of human genetics.

Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer.

J. Céraline, J. Bergerat, P. Kessler, 2008, Advances in experimental medicine and biology.

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer

J. Céraline, T. Ye, C. Keime, 2017, Oncotarget.